Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-21-004512)

Filing Details

Accession Number:: 0001415889-21-004512
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-21 17:53:46
Reporting Period:: 2021-09-20

Accepted Time:: 2021-09-21 17:53:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1790340	Immuneering Corp	IMRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1870076	Peter Feinberg	245 Main Street Second Floor Cambridge MA 02142		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-09-20	4,750	$24.45	5,099	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	392,242	Indirect	General Partner of PF Associates L.P.
Class A Common Stock	476,615	Indirect	General Partner of PEF LLC.
Class A Common Stock	115,441	Indirect	General Partner of S4K Investments LLC.

Footnotes

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.75 to $24.75. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.